RecruitingNCT06098430
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Studying Nodular lymphocyte predominant Hodgkin lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- St. Jude Children's Research Hospital
- Principal Investigator
- Valerie Crabtree, PhDSt. Jude Children's Research Hospital
- Enrollment
- 100 target
- Eligibility
- 8 years · All sexes
- Timeline
- 2024 – 2028
Study locations (5)
- University of Colorado Hospital, Aurora, Colorado, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- The University of Rochester Medical Center, Rochester, New York, United States
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06098430 on ClinicalTrials.govOther trials for Nodular lymphocyte predominant Hodgkin lymphoma
Additional recruiting or active studies for the same condition.
See all trials for Nodular lymphocyte predominant Hodgkin lymphoma →